About Pacific Diabetes Technologies
Pacific Diabetes Technologies is a company based in Portland (United States) founded in 2011. Pacific Diabetes Technologies has raised $6.52 million across 10 funding rounds from investors including NIH, HHS and Cascadia Venture Forum. Pacific Diabetes Technologies offers products and services including SynerG. Pacific Diabetes Technologies operates in a competitive market with competitors including Admetsys, TypeZero Technologies, Cellnovo, Ideal Medical Technologies and Animas, among others.
- Headquarter Portland, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pacific Diabetes Technologies, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6.52 M (USD)
in 10 rounds
-
Latest Funding Round
$2.92 M (USD), Series A
Oct 06, 2025
-
Investors
NIH
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pacific Diabetes Technologies
Pacific Diabetes Technologies offers a comprehensive portfolio of products and services, including SynerG.
A single device for continuous glucose monitoring and insulin site management.
People of Pacific Diabetes Technologies
Unlock access to complete
Unlock access to complete
Funding Insights of Pacific Diabetes Technologies
Pacific Diabetes Technologies has successfully raised a total of $6.52M across 10 strategic funding rounds. The most recent funding activity was a Series A round of $2.92 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Pacific Diabetes Technologies
Pacific Diabetes Technologies has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, HHS and Cascadia Venture Forum.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
A charitable trust focused on healthcare and research funding.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Pacific Diabetes Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pacific Diabetes Technologies
Investment portfolio details for Pacific Diabetes Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pacific Diabetes Technologies
Detailed financials for Pacific Diabetes Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pacific Diabetes Technologies Comparisons
Peer comparison for Pacific Diabetes Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pacific Diabetes Technologies
Pacific Diabetes Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Admetsys, TypeZero Technologies, Cellnovo, Ideal Medical Technologies and Animas, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of a closed-loop system for insulin and glucose delivery
|
|
| Locked | Locked | Locked |
Device for continuous glucose monitoring with manually operated insulin delivery
|
|
| Locked | Locked | Locked |
Offers online slot gaming with bonuses, promotions, and secure interface.
|
|
| Locked | Locked | Locked |
An AI-based artificial pancreas system is developed for ICU patients.
|
|
| Locked | Locked | Locked |
Device for continuous glucose monitoring with manual insulin administration
|
Detailed competitors of Pacific Diabetes Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pacific Diabetes Technologies
Complete news archive for Pacific Diabetes Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pacific Diabetes Technologies
Pacific Diabetes Technologies was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Pacific Diabetes Technologies is headquartered in Portland, United States. It is registered at Portland, Oregon, United States.
Pacific Diabetes Technologies is a funded company, having raised a total of $6.52M across 10 funding rounds to date.
Pacific Diabetes Technologies (PDT) aims to create an accessible integrated artificial pancreas which is a result of sensor chemistry with microelectronic fabrication technologies. The device is intended to be used for Type 1 diabetes or insulin-treated Type 2 diabetes and as of Nov 2015, it is not approved for human use. The first device of the company performs glucose sensing and hormone delivery, consisting of an insertion tool, electronic sensor module, insulin infusion line connector, and sensing catheter sensor house. This system provides diabetes management solution as it combines multiple amperometric glucose sensing units with insulin delivery in a single unified device.
Pacific Diabetes Technologies's top competitors include Admetsys, TypeZero Technologies and Ideal Medical Technologies.
Pacific Diabetes Technologies offers SynerG.
Pacific Diabetes Technologies has 4 investors. Key investors include NIH, HHS, Cascadia Venture Forum, and Helmsley Charitable Trust.